Skip to main content
Top
Published in: Digestive Diseases and Sciences 6/2012

01-06-2012 | Original Article

Performance of Platelet Count/Spleen Diameter Ratio for Diagnosis of Esophageal Varices in Cirrhosis: A Meta-Analysis

Authors: Li Ying, Xiao Lin, Zuo-Liu Xie, Yuan-Ping Hu, Ke-Qing Shi

Published in: Digestive Diseases and Sciences | Issue 6/2012

Login to get access

Abstract

Background

Platelet count/spleen diameter ratio (PSR) is a non-invasive method for the assessment of esophageal varices (EV), developed as an alternative to endoscopy.

Aim

To assess the performance of PSR for diagnosis of EV using meta-analysis.

Methods

PubMed, EMBASE, the Cochrane Library, ISI web of Knowledge, China National Knowledge Infrastructure, and article references were searched. We included studies using endoscopy as a reference standard, with the data necessary to calculate the true and false positive, true and false negative diagnostic results of PSR for EV. The quality of the studies was rated with the QUADAS tool. The hierarchical summary receiver operating characteristic (HSROC) was used to examine the PSR accuracy for the diagnosis of EV. Heterogeneity was explored using meta-regression. Clinical utility of PSR for EV was evaluated by a Fagan plot.

Results

In 20 studies (n = 3,063), the HSROC of the PSR for EV was 0.95 at various thresholds. At the threshold of 909, the summary sensitivities and specificities were 0.92 (95% CI, 0.79–0.97) and 0.87 (95% CI, 0.76–0.93), respectively. The HSROC was also 0.95 at the threshold of 909. If PSR was below 909 for EV (“positive” result), the post-test probability (if pre-test probability was 50%) was 87%, while if PSR was at or over 909 (“negative” result), the post-test probability was only 9%. PSR also had a high accuracy in diagnosis of EV in patients with compensated cirrhosis.

Conclusions

PSR can identify EV in cirrhosis with a high accuracy. Application of this index may decrease the need for endoscopy among cirrhotic patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007;46:922–938.PubMedCrossRef Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007;46:922–938.PubMedCrossRef
2.
go back to reference Garcia-Tsao G, Bosch J. Management of varices and variceal hemorrhage in cirrhosis. N Engl J Med. 2010;362:823–832.PubMedCrossRef Garcia-Tsao G, Bosch J. Management of varices and variceal hemorrhage in cirrhosis. N Engl J Med. 2010;362:823–832.PubMedCrossRef
3.
go back to reference de Franchis R. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2010;53:762–768.PubMedCrossRef de Franchis R. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2010;53:762–768.PubMedCrossRef
4.
go back to reference Eisen GM, Baron TH, Dominitz JA, et al. Complications of upper GI endoscopy. Gastrointest Endosc. 2002;55:784–793.PubMedCrossRef Eisen GM, Baron TH, Dominitz JA, et al. Complications of upper GI endoscopy. Gastrointest Endosc. 2002;55:784–793.PubMedCrossRef
5.
go back to reference Merli M, Nicolini G, Angeloni S, et al. Incidence and natural history of small esophageal varices in cirrhotic patients. J Hepatol. 2003;38:266–272.PubMedCrossRef Merli M, Nicolini G, Angeloni S, et al. Incidence and natural history of small esophageal varices in cirrhotic patients. J Hepatol. 2003;38:266–272.PubMedCrossRef
6.
go back to reference Kim BK, Han KH, Park JY, et al. A liver stiffness measurement-based, noninvasive prediction model for high-risk esophageal varices in B-viral liver cirrhosis. Am J Gastroenterol. 2010;105:1382–1390.PubMedCrossRef Kim BK, Han KH, Park JY, et al. A liver stiffness measurement-based, noninvasive prediction model for high-risk esophageal varices in B-viral liver cirrhosis. Am J Gastroenterol. 2010;105:1382–1390.PubMedCrossRef
7.
go back to reference Sebastiani G, Tempesta D, Fattovich G, et al. Prediction of oesophageal varices in hepatic cirrhosis by simple serum non-invasive markers: results of a multicenter, large-scale study. J Hepatol. 2010;53:630–638.PubMedCrossRef Sebastiani G, Tempesta D, Fattovich G, et al. Prediction of oesophageal varices in hepatic cirrhosis by simple serum non-invasive markers: results of a multicenter, large-scale study. J Hepatol. 2010;53:630–638.PubMedCrossRef
8.
go back to reference Tarantino G, Citro V, Esposito P, et al. Blood ammonia levels in liver cirrhosis: a clue for the presence of portosystemic collateral veins. BMC Gastroenterol. 2009;9:21.PubMedCrossRef Tarantino G, Citro V, Esposito P, et al. Blood ammonia levels in liver cirrhosis: a clue for the presence of portosystemic collateral veins. BMC Gastroenterol. 2009;9:21.PubMedCrossRef
9.
go back to reference Giannini E, Botta F, Borro P, et al. Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis. Gut. 2003;52:1200–1205.PubMedCrossRef Giannini E, Botta F, Borro P, et al. Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis. Gut. 2003;52:1200–1205.PubMedCrossRef
10.
go back to reference Giannini EG, Zaman A, Kreil A, et al. Platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices: results of a multicenter, prospective, validation study. Am J Gastroenterol. 2006;101:2511–2519.PubMedCrossRef Giannini EG, Zaman A, Kreil A, et al. Platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices: results of a multicenter, prospective, validation study. Am J Gastroenterol. 2006;101:2511–2519.PubMedCrossRef
11.
go back to reference Camma C, Petta S, Di Marco V, et al. Insulin resistance is a risk factor for esophageal varices in hepatitis C virus cirrhosis. Hepatology. 2009;49:195–203.PubMedCrossRef Camma C, Petta S, Di Marco V, et al. Insulin resistance is a risk factor for esophageal varices in hepatitis C virus cirrhosis. Hepatology. 2009;49:195–203.PubMedCrossRef
12.
go back to reference Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003;3:25.PubMedCrossRef Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003;3:25.PubMedCrossRef
13.
go back to reference Doust JA, Glasziou PP, Pietrzak E, Dobson AJ. A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure. Arch Intern Med. 2004;164:1978–1984.PubMedCrossRef Doust JA, Glasziou PP, Pietrzak E, Dobson AJ. A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure. Arch Intern Med. 2004;164:1978–1984.PubMedCrossRef
14.
go back to reference Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560.PubMedCrossRef Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560.PubMedCrossRef
15.
go back to reference Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol. 2005;58:882–893.PubMedCrossRef Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol. 2005;58:882–893.PubMedCrossRef
16.
go back to reference Hellmich M, Lehmacher W. A ruler for interpreting diagnostic test results. Methods Inf Med. 2005;44:124–126.PubMed Hellmich M, Lehmacher W. A ruler for interpreting diagnostic test results. Methods Inf Med. 2005;44:124–126.PubMed
17.
go back to reference Legasto GM, Sevilla J, Balay A, et al. Platelet count/spleen diameter ratio: a noninvasive parameter to predict the presence of esophageal varices. Phillippine J Gastroenterol. 2006;2:33–38. Legasto GM, Sevilla J, Balay A, et al. Platelet count/spleen diameter ratio: a noninvasive parameter to predict the presence of esophageal varices. Phillippine J Gastroenterol. 2006;2:33–38.
18.
go back to reference Agha A, Anwar E, Bashir K, Savarino V, Giannini EG. External validation of the platelet count/spleen diameter ratio for the diagnosis of esophageal varices in hepatitis C virus-related cirrhosis. Dig Dis Sci. 2009;54:654–660.PubMedCrossRef Agha A, Anwar E, Bashir K, Savarino V, Giannini EG. External validation of the platelet count/spleen diameter ratio for the diagnosis of esophageal varices in hepatitis C virus-related cirrhosis. Dig Dis Sci. 2009;54:654–660.PubMedCrossRef
19.
go back to reference Makarem MA, Shatat ME, Shaker Y, et al. Platelet count/bipolar spleen diameter ratio for the prediction of esophageal varices: the special Egyptian situation. Hepatitis Monthly. 2011;11:278–284. Makarem MA, Shatat ME, Shaker Y, et al. Platelet count/bipolar spleen diameter ratio for the prediction of esophageal varices: the special Egyptian situation. Hepatitis Monthly. 2011;11:278–284.
20.
go back to reference Baig WW, Nagaraja MV, Varma M, Prabhu R. Platelet count to spleen diameter ratio for the diagnosis of esophageal varices: is it feasible? Can J Gastroenterol. 2008;22:825–828.PubMed Baig WW, Nagaraja MV, Varma M, Prabhu R. Platelet count to spleen diameter ratio for the diagnosis of esophageal varices: is it feasible? Can J Gastroenterol. 2008;22:825–828.PubMed
21.
go back to reference Barikbin R, Hekmatnia A, Omidifar N, Farghadani M, Adibi P. Prediction severity of esophageal varices: a new cutoff point for platelet count/spleen diameter ratio. Minerva Gastroenterol Dietol. 2010;56:1–6.PubMed Barikbin R, Hekmatnia A, Omidifar N, Farghadani M, Adibi P. Prediction severity of esophageal varices: a new cutoff point for platelet count/spleen diameter ratio. Minerva Gastroenterol Dietol. 2010;56:1–6.PubMed
22.
go back to reference Cherian JV, Deepak N, Ponnusamy RP, Somasundaram A, Jayanthi V. Non-invasive predictors of esophageal varices. Saudi J Gastroenterol. 2011;17:64–68.PubMedCrossRef Cherian JV, Deepak N, Ponnusamy RP, Somasundaram A, Jayanthi V. Non-invasive predictors of esophageal varices. Saudi J Gastroenterol. 2011;17:64–68.PubMedCrossRef
23.
go back to reference Lei JB, Huang TZ. Value of the platelet count/spleen diameter ratio on predicting esophageal varices of liver cirrhosis [In Chinese]. Pract Clin Med. 2007;8:25–27. Lei JB, Huang TZ. Value of the platelet count/spleen diameter ratio on predicting esophageal varices of liver cirrhosis [In Chinese]. Pract Clin Med. 2007;8:25–27.
24.
go back to reference Stefanescu H, Grigorescu M, Lupsor M, Procopet B, Maniu A, Badea R. Spleen stiffness measurement using Fibroscan for the noninvasive assessment of esophageal varices in liver cirrhosis patients. J Gastroenterol Hepatol. 2011;26:164–170.PubMedCrossRef Stefanescu H, Grigorescu M, Lupsor M, Procopet B, Maniu A, Badea R. Spleen stiffness measurement using Fibroscan for the noninvasive assessment of esophageal varices in liver cirrhosis patients. J Gastroenterol Hepatol. 2011;26:164–170.PubMedCrossRef
25.
go back to reference Yu JY, Liu XN, Wang D, Cui JJ. Non-invasive predictive factors of esophageal varices in patients with post-hepatitis B cirrhosis [In Chinese]. J Binzhou Medical University. 2008;31. Yu JY, Liu XN, Wang D, Cui JJ. Non-invasive predictive factors of esophageal varices in patients with post-hepatitis B cirrhosis [In Chinese]. J Binzhou Medical University. 2008;31.
26.
go back to reference Barrera F, Riquelme A, Soza A, et al. Platelet count/spleen diameter ratio for non-invasive prediction of high risk esophageal varices in cirrhotic patients. Ann Hepatol. 2009;8:325–330.PubMed Barrera F, Riquelme A, Soza A, et al. Platelet count/spleen diameter ratio for non-invasive prediction of high risk esophageal varices in cirrhotic patients. Ann Hepatol. 2009;8:325–330.PubMed
27.
go back to reference Mattos AZ, Mattos AA, Vianna FF, Musskopf MI, Pereira-Lima JC, Maciel AC. Platelet count/spleen diameter ratio: analysis of its capacity as a predictor of the existence of esophageal varices. Arq Gastroenterol. 2010;47:275–278.PubMedCrossRef Mattos AZ, Mattos AA, Vianna FF, Musskopf MI, Pereira-Lima JC, Maciel AC. Platelet count/spleen diameter ratio: analysis of its capacity as a predictor of the existence of esophageal varices. Arq Gastroenterol. 2010;47:275–278.PubMedCrossRef
28.
go back to reference Sethar GH, Ahmed R, Rathi SK, Shaikh NA. Platelet count/splenic size ratio: a parameter to predict the presence of esophageal varices in cirrhotics. J Coll Physicians Surg Pak. 2006;16:183–186.PubMed Sethar GH, Ahmed R, Rathi SK, Shaikh NA. Platelet count/splenic size ratio: a parameter to predict the presence of esophageal varices in cirrhotics. J Coll Physicians Surg Pak. 2006;16:183–186.PubMed
29.
go back to reference Tao W, Yang SQ, Lv XC, Yang L. Value of the platelet count/spleen diameter ratio on diagnosis of esophageal varices in patients with cirrhosis [In Chinese]. J Ningxia Med Coll. 2008;30:349–350. Tao W, Yang SQ, Lv XC, Yang L. Value of the platelet count/spleen diameter ratio on diagnosis of esophageal varices in patients with cirrhosis [In Chinese]. J Ningxia Med Coll. 2008;30:349–350.
30.
go back to reference Nashaat EH, Abd-Elaziz H, Sabry M, Ibrahim AA. Non-endoscopic predictors of esophageal varices and portal hypertensive gastropathy. Nature Sci. 2010;8:43–50. Nashaat EH, Abd-Elaziz H, Sabry M, Ibrahim AA. Non-endoscopic predictors of esophageal varices and portal hypertensive gastropathy. Nature Sci. 2010;8:43–50.
31.
go back to reference Schwarzenberger E, Meyer T, Golla V, Sahdala NP, Min AD. Utilization of platelet count spleen diameter ratio in predicting the presence of esophageal varices in patients with cirrhosis. J Clin Gastroenterol. 2010;44:146–150.PubMedCrossRef Schwarzenberger E, Meyer T, Golla V, Sahdala NP, Min AD. Utilization of platelet count spleen diameter ratio in predicting the presence of esophageal varices in patients with cirrhosis. J Clin Gastroenterol. 2010;44:146–150.PubMedCrossRef
32.
go back to reference Esmat S, Omran D. Study of the right liver lobe size/albumin ratio as a noninvasive predictor of oesophageal varices compared to: spleen size, platelet count and platelet count/spleen diameter ratio in post hepatitis C virus liver cirrhosis in Egypt. J American Sci. 2011;7:962–968. Esmat S, Omran D. Study of the right liver lobe size/albumin ratio as a noninvasive predictor of oesophageal varices compared to: spleen size, platelet count and platelet count/spleen diameter ratio in post hepatitis C virus liver cirrhosis in Egypt. J American Sci. 2011;7:962–968.
33.
go back to reference de Franchis R. Non-invasive (and minimally invasive) diagnosis of oesophageal varices. J Hepatol. 2008;49:520–527.PubMedCrossRef de Franchis R. Non-invasive (and minimally invasive) diagnosis of oesophageal varices. J Hepatol. 2008;49:520–527.PubMedCrossRef
Metadata
Title
Performance of Platelet Count/Spleen Diameter Ratio for Diagnosis of Esophageal Varices in Cirrhosis: A Meta-Analysis
Authors
Li Ying
Xiao Lin
Zuo-Liu Xie
Yuan-Ping Hu
Ke-Qing Shi
Publication date
01-06-2012
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 6/2012
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-012-2058-y

Other articles of this Issue 6/2012

Digestive Diseases and Sciences 6/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine